Surgical Site Infection Control Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Surgical Site Infection Control Market is segmented by Product, Surgery/Procedure, Type of Indication, End User (Hospitals and Ambulatory Surgical Centers), and Geography.

Market Snapshot

surgical site infection control market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Currently, the global SSI control market has been in a growing phase and is dominated by hospitals and developed regions, like North America. The increasing hospital-acquired infections and number of surgeries have been increasingly driving the SSI control market across the world. 

  • Increased focus on preventing SSI through appropriate measures has further augmented the market studied in developed regions. Awareness about surgical site infections has also been higher in the developed regions. 
  • This has led to the higher adoption of SSI control products, thus, preventing infections among people. The increasing geriatric population has also impacted the studied market positively.

Scope of the Report

As per the scope of this report, surgical site infection (SSI) is an infection that occurs after surgery, in that part of the body where the surgery has been done. Surgical site infections can be superficial, deep incisional, or organ related. 

By Product
Manual Reprocessors Solution
Hand Disinfectants
Skin Disinfectants
Surgical Scrubs
Hair Clippers
Surgical Drapes
Surgical Irrigation
Skin Preparation Solution
Medical Nonwovens
Surgical Gloves
Other Products
By Surgery/Procedure
Cataract Surgery
Cesarean Section
Dental Restoration
Gastric Bypass
Other Surgeries/Procedures
By Type of Infection
Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI
By End User
Ambulatory Surgical Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There has been an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.

surgical site infection control market

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America has been dominating the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs have been considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.

surgical site infection control market

Competitive Landscape

3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Group, and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Hospital Acquired Infection

      2. 4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control

      3. 4.2.3 Increasing Number of Surgeries

      4. 4.2.4 Rapidly Growing Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness of Hospital Infection Prevention and Control

      2. 4.3.2 Increased Use of Outpatient Treatment

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Manual Reprocessors Solution

      2. 5.1.2 Disinfectants

        1. Hand Disinfectants

        2. Skin Disinfectants

      3. 5.1.3 Surgical Scrubs

      4. 5.1.4 Hair Clippers

      5. 5.1.5 Surgical Drapes

      6. 5.1.6 Surgical Irrigation

      7. 5.1.7 Skin Preparation Solution

      8. 5.1.8 Medical Nonwovens

      9. 5.1.9 Surgical Gloves

      10. 5.1.10 Other Products

    2. 5.2 By Surgery/Procedure

      1. 5.2.1 Cataract Surgery

      2. 5.2.2 Cesarean Section

      3. 5.2.3 Dental Restoration

      4. 5.2.4 Gastric Bypass

      5. 5.2.5 Other Surgeries/Procedures

    3. 5.3 By Type of Infection

      1. 5.3.1 Superficial Incisional SSI

      2. 5.3.2 Deep Incisional SSI

      3. 5.3.3 Organ or Space SSI

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Ambulatory Surgical Centers

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 3M

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Belimed AG

      4. 6.1.4 bioMerieux SA

      5. 6.1.5 Getinge Group

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Kimberly-Clark Corporation

      8. 6.1.8 Sotera Health

      9. 6.1.9 Ansell Limited

      10. 6.1.10 Steris Corporation

      11. 6.1.11 Lac-Mac Limited

      12. 6.1.12 Pacon Manufacturing Corp.

      13. 6.1.13 American Polyfilm Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Surgical Site Infection Control Market market is studied from 2018 - 2026.

The Surgical Site Infection Control Market is growing at a CAGR of 0% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

3M, Becton, Dickinson and Company, bioMerieux SA, Getinge Group, Johnson & Johnson are the major companies operating in Surgical Site Infection Control Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!